The Art of Gene Therapy Digital Summit

Register today for The Art of Gene Therapy Digital Summit, a live two-day event on July 28-29, 2020, featuring industry-leading gene therapy companies and regulatory agencies such as the FDA, RhiaPharmaceutical, Orchard Therapeutics, bluebird bio, REGENXBIO and many more.

The digital summit will shine a light on gene therapy future technologies, technical challenges, lessons learned from scale up to commercialization and what is on the horizon for regulatory guidelines.

Presentation

Wednesday, July 29
11:00am – 12:00pm ET
The Next Decade of Gene Therapy: Q&A panel discussion

RhiaPharmaceutical’s Andy Holt, VP Business Development, joins a panel of gene therapy leaders from REGENXBIO, Orchard Therapeutics, In Vivo and MilliporeSigma to discuss what’s next in the industry.